Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
94.6 EUR
-3.86%
Market Closed
Updated:
May 21, 2024
Gerresheimer AG
EPS (Diluted)
|
Gerresheimer AG
EPS (Diluted) Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
EPS (Diluted)
€3
|
CAGR 3-Years
4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
5%
|
|
E
|
Evotec SE
XETRA:EVT
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
EPS (Diluted)
€1
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's EPS (Diluted)?
EPS (Diluted)
3.4
EUR
3.4
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's EPS (Diluted) amounts to 3.4 EUR.
What is Gerresheimer AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
5%
5%
Over the last year, the EPS (Diluted) growth was 9%. The average annual EPS (Diluted) growth rates for Gerresheimer AG have been 4% over the past three years , -10% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
